Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Franco

Showing results (101-110 of 1,431) with videos related to

Pageof 144
Sort By:
Epigenomics|September 25, 2024
Will methylation assays be part of a full molecular strategy to improve clinical management of cervical neoplasia?Mariam El-Zein, Eduardo L Franco
The Journal of Infectious Diseases|September 18, 2021
ReplyEduardo L Franco, Mariam El-Zein
Pediatrics|July 1, 1979
Steroid rosacea in childrenH L Franco, W L Weston
The Journal of Biological Chemistry|August 2, 1996
Core histones are glutaminyl substrates for tissue transglutaminaseE Ballestar, C Abad, L Franco
Cancer|June 15, 1991
Single-dose versus fractionated-dose dactinomycin in the treatment of Wilms' tumor. Preliminary results of a clinical trial. The Brazilian Wilms' Tumor Study GroupB de Camargo, E L Franco
Epidemiology (Cambridge, Mass.)|September 1, 1996
Use of dipyrone during pregnancy and risk of Wilms' tumor. Brazilian Wilms' Tumor Study GroupC R Sharpe, E L Franco
Vaccine|November 26, 2008
Cost-effectiveness analysis: an essential tool to inform public health policy in cervical cancer preventionEduardo L Franco, Michael F Drummond
The International Journal of Biochemistry & Cell Biology|August 9, 2005
Plant gamma-thionins: novel insights on the mechanism of action of a multi-functional class of defense proteinsPatrícia B Pelegrini, Octávio L Franco
Cancer|June 15, 1994
A randomized clinical trial of single-dose versus fractionated-dose dactinomycin in the treatment of Wilms' tumor. Results after extended follow-up. Brazilian Wilms' Tumor Study GroupB de Camargo, E L Franco
International Journal of Dermatology|October 1, 1992
Saperconazole in the treatment of systemic and subcutaneous mycosesL Franco, I Gomez, A Restrepo
Pageof 144

Showing results (101-110 of 1,431) with videos related to

Sort By:
Pageof 144
Epigenomics|September 25, 2024
Will methylation assays be part of a full molecular strategy to improve clinical management of cervical neoplasia?Mariam El-Zein, Eduardo L Franco
The Journal of Infectious Diseases|September 18, 2021
ReplyEduardo L Franco, Mariam El-Zein
Pediatrics|July 1, 1979
Steroid rosacea in childrenH L Franco, W L Weston
The Journal of Biological Chemistry|August 2, 1996
Core histones are glutaminyl substrates for tissue transglutaminaseE Ballestar, C Abad, L Franco
Cancer|June 15, 1991
Single-dose versus fractionated-dose dactinomycin in the treatment of Wilms' tumor. Preliminary results of a clinical trial. The Brazilian Wilms' Tumor Study GroupB de Camargo, E L Franco
Epidemiology (Cambridge, Mass.)|September 1, 1996
Use of dipyrone during pregnancy and risk of Wilms' tumor. Brazilian Wilms' Tumor Study GroupC R Sharpe, E L Franco
Vaccine|November 26, 2008
Cost-effectiveness analysis: an essential tool to inform public health policy in cervical cancer preventionEduardo L Franco, Michael F Drummond
The International Journal of Biochemistry & Cell Biology|August 9, 2005
Plant gamma-thionins: novel insights on the mechanism of action of a multi-functional class of defense proteinsPatrícia B Pelegrini, Octávio L Franco
Cancer|June 15, 1994
A randomized clinical trial of single-dose versus fractionated-dose dactinomycin in the treatment of Wilms' tumor. Results after extended follow-up. Brazilian Wilms' Tumor Study GroupB de Camargo, E L Franco
International Journal of Dermatology|October 1, 1992
Saperconazole in the treatment of systemic and subcutaneous mycosesL Franco, I Gomez, A Restrepo
Pageof 144